1. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992 Jul 4;340(8810):17-8.
2. Glazener CM, Ford WC, Hull MG. The prognostic power of the post-coital test for natural conception depends on duration of infertility. Hum Reprod. 2000 Sep;15(9):1953-7.
3. Jarow JP, Sharlip ID, Belker AM, et al. Male Infertility Best Practice Policy Committee of the American Urological Association Inc. Best practice policies for male infertility. J Urol. 2002 May;167(5):2138-44.
4. Aydos K: Üremeye yardımcı teknikler uygulanacak çiftlerde erkeğin hazırlanması. Klinik Adroloji, Özdiler E, Aydos K (ed), Ankara Üniversitesi Basımevi, 2000.
5. Aydos K, Unlu C, Demirel LC, Evirgen O, Tolunay O. The effect of pure FSH administration in non-obstructive azoospermic men on testicular sperm retrieval. Eur J Obstet Gynecol Reprod Biol. 2003 May 1;108(1):54-8.
6. Baccetti B, Strehler E, Capitani S, Collodel G, De Santo M, Moretti E, Piomboni P, Wiedeman R, Sterzik K. The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae 11). Hum Reprod 1997 Sep;12(9):1955-68.
7. Bartoov B, Eltes F, Lunenfeld E, Har-Even D, Lederman H, Lunenfeld B. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 1994 Apr;61(4):727-34.
8. Ben-Rafael Z, Farhi J, Feldberg D, Bartoov B, Kovo M, Eltes F, Ashkenazi J. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 2000 Jan;73(1):24-30.
9. Arnaldi G, Balercia G, Barbatelli G, Mantero F. Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia. Andrologia 2000 May;32(3):155-61.
10. Caroppo E, Niederberger C, Vizziello GM, D'Amato G. Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. Fertil Steril. 2003 Dec;80(6):1398-403.
11. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol. 2002 Feb;167(2 Pt 1):624-9.
12. Adamopoulos DA, Nicopoulou S, Kapolla N, Karamertzanis M, Andreou E. The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia. Fertil Steril. 1997 Apr;67(4):756-62.
13. Suleiman SA, Ali ME, Zaki ZM, el Malik EM, Nasr MA: Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996 17: 530-7.
14. Barkay J, Harpaz-Kerpel S, Ben-Ezra S, Gordon S, Zuckerman H. The prostaglandin inhibitor effect of antiinflammatory drugs in the therapy of male infertility. Fertil Steril. 1984 Sep;42(3):406-11.
15. Toth A, Leser ML, Brooks C, et al: Subsequent pregnancies among 161 couples treated for T-mycoplasma genital tract infection. N Eng J Med. 1983, 308: 505-7.
16. Vicar E: Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection. Hum Reprod 2000; 15: 2536-44.
17. Berger RE, Smith WD, Critchlow CW, Stenchever MA, Moore DE, Spadoni LR, Holmes KK. Improvement in the sperm penetration (hamster ova) assay (SPA) results after doxycycline treatment of infertile men. J Androl. 1983 Mar-Apr;4(2):126-30.
18. Aparicio NJ, Schwarzstein L, de Turner EA. Pentoxifylline (BL 191) by oral administration in the treatment of asthenozoospermia. Andrologia. 1980 May-Jun;12(3):228-31.
19. Hendry WF, Hughes L, Scammell G, Pryor JP, Hargreave TB. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet 1990 Jan 13;335(8681):85-8.
20. Kapolla N, Pappa a, Nicopoulou SC, Andreou E, Koukkou E, Gregoriou A, Karamertzanis M, Adamopoulos DA: Sertoli cell reserve capacity in normozoospermic and oligozoospermic men. Int J Androl 2000; 23 (Suppl 1), 1-68.
21. Acosta AA, Khalifa E, Oehninger S. Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Hum Reprod 1992 Sep;7(8):1067-72.
22. Oehninger S. Pathophysiology of oligoasthenoteratozoospermia: are we improving in the diagnosis? RBM Online. 2003, 7; 59-65.
23. Lee RK, Hou JW, Ho HY, et al. Sperm morphology analysis using strict criteria as a prognostic factor in intrauterine insemination. Int J Androl. 2002 Oct;25(5):277-80.
24. Montanaro Gauci M, Kruger TF, Coetzee K, et al. Stepwise regression analysis to study male and female factors impacting on pregnancy rate in an intrauterine insemination programme. Andrologia. 2001 May;33(3):135-41.
25. Ombelet W, Bosmans E, Janssen M, et al. Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Hum Reprod. 1997 May;12(5):987-93.
26. Acosta AA, Oehninger S, Ertunc H, Philput C. Possible role of pure human follicle-stimulating hormone in the treatment of severe male-factor infertility by assisted reproduction: preliminary report. Fertil Steril. 1991 Jun;55(6):1150-6.
27. Lahteenmaki A, Reima I, Hovatta O. Treatment of severe male immunological infertility by intracytoplasmic sperm injection. Hum Reprod. 1995 Nov;10(11):2824-8.
28. Krapez JA, Hayden CJ, Rutherford AJ, Balen AH. Survey of the diagnosis and management of antisperm antibodies. Hum Reprod. 1998 Dec;13(12):3363-7.